At a glance
Influenza vaccine effectiveness from the US Flu VE Network for the 2019-2020 U.S. flu season. Adjusted vaccine effectiveness against flu illness for all ages was 39%.
Description of patients enrolled in the US Flu VE Network, 2019-2020
Age
Age | Number | % Total |
---|---|---|
6 months-8 years | 2011 | 23 |
9-17 years | 1193 | 13 |
18-49 years | 3258 | 37 |
50-64 years | 1348 | 15 |
65+ years | 1035 | 12 |
Sex
Sex | Number | % Total |
---|---|---|
Male | 3675 | 42 |
Female | 5169 | 58 |
Unknown | 1 | <1 |
Race/ethnicity
Race | Number | % Total |
---|---|---|
White, non-Hispanic | 894 | 10 |
Black, non-Hispanic | 834 | 9 |
Hispanic | 801 | 9 |
Other, non-Hispanic | 6294 | 71 |
Unknown | 22 | <1 |
Influenza A or B viruses
End of season influenza vaccine effectiveness for all vaccine types, against influenza A or B viruses
Age group (years) | Influenza positive Total |
Vaccinated influenza positive (% vaccinated) |
Influenza negative Total |
Vaccinated influenza negative (% vaccinated) |
Adjusted VE % | Adjusted 95% CI |
---|---|---|---|---|---|---|
All ages | 2722 | 1140 (42) | 6123 | 3388 (55) | 39 | (32, 44) |
6 mos–8 | 646 | 269 (42) | 1365 | 759 (56) | 34 | (19, 46) |
9–17 | 471 | 155 (33) | 722 | 324 (45) | 40 | (22, 53) |
18–49 | 1056 | 388 (37) | 2202 | 991 (45) | 34 | (23, 44) |
50–64 | 350 | 180 (51) | 998 | 619 (62) | 40 | (22, 54) |
≥65 | 199 | 148 (74) | 836 | 695 (83) | 39 | (9, 59) |
Influenza A(H1N1)pdm09 viruses
End of season influenza vaccine effectiveness for all vaccine types, against influenza A(H1N1)pdm09 viruses
Age group (years) | Influenza positive Total |
Vaccinated influenza positive (% vaccinated) |
Influenza negative Total |
Vaccinated influenza negative (% vaccinated) |
Adjusted VE % | Adjusted 95% CI |
---|---|---|---|---|---|---|
All ages | 1405 | 679 (48) | 6123 | 3388 (55) | 30 | (21, 39) |
6 mos–8 | 277 | 133 (48) | 1365 | 759 (56) | 23 | (-3, 42) |
9–17 | 132 | 53 (40) | 722 | 324 (45) | 29 | (-7, 52) |
18–49 | 576 | 242 (42) | 2202 | 991 (45) | 26 | (9, 39) |
50–64 | 273 | 142 (52) | 998 | 619 (62) | 40 | (20, 56) |
≥65 | 147 | 109 (74) | 836 | 695 (83) | 42 | (9, 64) |
Influenza B/Victoria viruses
End of season influenza vaccine effectiveness for all vaccine types, against influenza B/Victoria viruses
Age group (years) | Influenza positive Total |
Vaccinated influenza positive (% vaccinated) |
Influenza negative Total |
Vaccinated influenza negative (% vaccinated) |
Adjusted VE % | Adjusted 95% CI |
---|---|---|---|---|---|---|
All ages | 1209 | 415 (34) | 6123 | 3388 (55) | 45 | (37, 52) |
6 mos–8 | 348 | 129 (37) | 1365 | 759 (56) | 39 | (20, 54) |
9–17 | 329 | 100 (30) | 722 | 324 (45) | 43 | (23, 58) |
18–49 | 434 | 128 (29) | 2202 | 991 (45) | 45 | (30, 56) |
50–64 | 56 | 27 (48) | 998 | 619 (62) | 44 | (0, 68) |
≥65 | 42 | 31 (74) | 836 | 695 (83) | 34 | (-40, 69) |